View More View Less
  • 1 Faculdade de Medicina de Juazeiro do Norte, FMJ Ceará, Brazil
  • | 2 Faculdade de Medicina de Juazeiro do Norte, FMJ Ceará, Brazil
  • | 3 Faculdade de Medicina de Juazeiro do Norte, FMJ Ceará, Brazil
  • | 4 Faculdade de Medicina de Juazeiro do Norte, FMJ Ceará, Brazil
  • | 5 Faculdade de Medicina de Juazeiro do Norte, FMJ Ceará, Brazil
  • | 6 Faculdade de Medicina de Juazeiro do Norte, FMJ Ceará, Brazil
  • | 7 Faculdade de Medicina de Juazeiro do Norte, FMJ, and, 2Universidade Regional do Cariri, Urca Ceará, Brazil
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Serratia marcescens, a Gram-negative bacillus that belongs to the family Enterobacteriaceae, is a human opportunistic pathogen bacterium that causes many diseases, such as urinary tract infections, respiratory tract infections, bacteremia, conjunctivitis, endocarditis, meningitis and wound infections. Many plasmides that confers multi-drug resistance were discovered, such as virulence factors, like cytotoxins that damage epithelial cells. The main topic of this paper presents a review about the molecular traits evolved in the pathogenic processes mediated by Serratia and its mechanism of resistance to drugs.

  • Marty, K. B., Williams, C. L., Guynn, L. J., Benedik, M. J., Blanke, S. R.: Characterization of a cytotoxic factor in culture filtrates of Serratia marcescens.Infection and Immunity70(3), 1121-1128 (2002).

    'Characterization of a cytotoxic factor in culture filtrates of Serratia marcescens. ' () 70 Infection and Immunity : 1121 -1128.

    • Search Google Scholar
  • Johnson, J. S., Croall, J., Power J. S. F., Armstrong, G. R.: Fatal Serratia marcescens meningitis and myocarditis in a patient with an indwelling urinary catheter. J Clin Pathol51, 789-790 (1998).

    'Fatal Serratia marcescens meningitis and myocarditis in a patient with an indwelling urinary catheter ' () 51 J Clin Pathol : 789 -790.

    • Search Google Scholar
  • Ledermann, W.: Shakespeare y la prodigiosa historia de Serratia marcescens como marcador biológico. Rev Chil Infect. Edición aniversario; 74-75 (2003).

    'Shakespeare y la prodigiosa historia de Serratia marcescens como marcador biológico ' () Rev Chil Infect. Edición aniversario; : 74 -75.

    • Search Google Scholar
  • Hertle, R., Schwarz, H.: Serratia marcescens internalization and replication in human bladder epithelial cells. BMC Infectious Diseases4, 16 (2004).

    'Serratia marcescens internalization and replication in human bladder epithelial cells ' () 4 BMC Infectious Diseases : 16.

    • Search Google Scholar
  • Franzon, J. H., Santos, D. S.: A role for histone-like protein H1 (H-NS) in the regulation of hemolysin expression by Serratia marcescens. Regulation of Serratia marcescens hemolysin genes. Braz J Med Biol Res37(12), 1763-1769 (2004).

    'A role for histone-like protein H1 (H-NS) in the regulation of hemolysin expression by Serratia marcescens. Regulation of Serratia marcescens hemolysin genes ' () 37 Braz J Med Biol Res : 1763 -1769.

    • Search Google Scholar
  • Dossi, M. T., Escalona, M., Serrano, C., Silva, M. A., Juliet, C., Valdéz, A. F., Leiva, V., Fernandez, J.: Serratia marcescens: Descripción de un brote de infección intrahospitalaria. Rev Chil Infect19(4), 262-266 (2002).

    'Serratia marcescens: Descripción de un brote de infección intrahospitalaria ' () 19 Rev Chil Infect : 262 -266.

    • Search Google Scholar
  • Mahlen, S. D., Morrow, S. S., Abdalhamid, B., Hanson, N. D.: Analyses of ampC gene expression in Serratia marcescens reveal new regulatory properties. J Antimcrob Chem51, 791-802 (2003).

    'Analyses of ampC gene expression in Serratia marcescens reveal new regulatory properties ' () 51 J Antimcrob Chem : 791 -802.

    • Search Google Scholar
  • Goto, M., Yasuzawa, H., Higashi, T., Yamaguchi, Y., Kawanami, A., Mifune, S., Mori, H., Nakayama, H., Harada, K., Arakawa, Y.: Dependence of hydrolysis of β-lactams with a Zinc(II)-β-lactamase produced from Serratia marcescens (IMP-1) on pH and concentration of Zinc(II) ion: Dissociation of Zn(II) from IMP-1 in acidic medium. Biol Pharm Bull26(5), 589-594 (2003).

    'Dependence of hydrolysis of β-lactams with a Zinc(II)-β-lactamase produced from Serratia marcescens (IMP-1) on pH and concentration of Zinc(II) ion: Dissociation of Zn(II) from IMP-1 in acidic medium ' () 26 Biol Pharm Bull : 589 -594.

    • Search Google Scholar
  • Brito, A., Pérez, J., Andrade, E., Cerrada, O., Tovar, L., Guzmán, M., Carmona, O.: Resistencia de Serratia marcescens a los antimicrobianos en Venezuela. BSVM20(1), 31-36 (2000).

    'Resistencia de Serratia marcescens a los antimicrobianos en Venezuela ' () 20 BSVM : 31 -36.

    • Search Google Scholar
  • Dói, Y., Yokoyama, K., Yamane, K., Wachino, J., Shibata, N., Yagi, T., Shibayama, T., Kato, H., Arakawa, Y.: Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides. Antimicrob Agents Chemother48(2), 491-496 (2004).

    'Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides ' () 48 Antimicrob Agents Chemother : 491 -496.

    • Search Google Scholar
  • Barbosa, P. A., Morgado, A. M. C., Leonel, R. G., Rojas, G. L., González, R. G.: Marcadores fenotípicos de Serratia marcescens, aislada de un brote intrahospitalario. Rev Mex Patol Clín46(4), 238-242 (1999).

    'Marcadores fenotípicos de Serratia marcescens, aislada de un brote intrahospitalario ' () 46 Rev Mex Patol Clín : 238 -242.

    • Search Google Scholar
  • Kirikae, T., Tokunaga, O., Inoue, Y., Fukino, T., Saruta, K., Yoshikura, H., Kuratsuji, T., Miyanomae, T.: Molecular Epidemiology of methicilin-resistant Staphylococcus aureus, Pseudomonas aureginosa and Serratia marcescens in a long-term care facility for patients with severe motor and intellectual disabilities. Jpn J Infect Dis57, 78-80 (2004).

    'Molecular Epidemiology of methicilin-resistant Staphylococcus aureus, Pseudomonas aureginosa and Serratia marcescens in a long-term care facility for patients with severe motor and intellectual disabilities ' () 57 Jpn J Infect Dis : 78 -80.

    • Search Google Scholar
  • Kurz, C. L., Chauvet, S., Andrˆs, E., Aurouze, M., Vallet, I., Michel, G. P. F., Uh, M., Celli, J., Filloux, A., Bentzmann, S., Steinmetz, I., Hoffmann, J. A., Finlay, B. B., Gorvel, J. P., Ferrandon, D., Ewbank, J. J.: Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. The EMBO Journal22(7), 1451-1460 (2003).

    'Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening ' () 22 The EMBO Journal : 1451 -1460.

    • Search Google Scholar
  • Carbonel, G. V., Alfieri, A. F., Alfieri, A. A., Vidotto, M. C., Levy, C. E., Darini, A. C. E., Yanaguita, R. M.: Detection of cytotoxic activity on Vero cells in clinical isolates of Serratia marcescens.Braz J Med Biol Res30(11), 1291-1298 (1997).

    'Detection of cytotoxic activity on Vero cells in clinical isolates of Serratia marcescens. ' () 30 Braz J Med Biol Res : 1291 -1298.

    • Search Google Scholar
  • Carbonell, V., Amorim, C. R. N., Furumura, M. T., Darin, A. L. C., Fonseca, B. A. L., Yano, T.: Biological activity of Serratia marcescens cytotoxin. Braz J Med Biol Res36(3), 351-359 (2003).

    'Biological activity of Serratia marcescens cytotoxin ' () 36 Braz J Med Biol Res : 351 -359.

    • Search Google Scholar
  • Chen, J., Lee, E. W., Kuroda, T., Mizushima, T., Tsuchiya, T.: Multidrug resistance in Serratia marcescens and cloning of genes responsible for the resistance. Biol Pharm Bull26(3), 391-393 (2003).

    'Multidrug resistance in Serratia marcescens and cloning of genes responsible for the resistance ' () 26 Biol Pharm Bull : 391 -393.

    • Search Google Scholar
  • Kumar, A., Worobec, E. A.: Fluoroquinolone resistance of Serratia marcescens: involvement of a proton gradient-dependent efflux pump. J Antimicrob Chem5, 593-596 (2002).

    'Fluoroquinolone resistance of Serratia marcescens: involvement of a proton gradient-dependent efflux pump ' () 5 J Antimicrob Chem : 593 -596.

    • Search Google Scholar
  • Berlanga, M., Viˆas, M.: Salicylate induction of phenotypic resistance to quinolones in Serratia marcescens.J Antimicrob Chem46, 279-282 (2000).

    'Salicylate induction of phenotypic resistance to quinolones in Serratia marcescens. ' () 46 J Antimicrob Chem : 279 -282.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 40 0 0
May 2021 30 1 1
Jun 2021 40 0 0
Jul 2021 19 0 0
Aug 2021 44 0 0
Sep 2021 8 1 2
Oct 2021 0 0 0